Linnaeus Therapeutics, Inc. announced the presentation of clinical data from its phase 1 dose-escalation study of LNS8801 as a...
Read more
MixComm announced the latest addition to its portfolio of breakthrough front-end ICs for 5G mmWave. The SUMMIT 3741 integrates...
Read more
Foldax announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve....
Read more
The approval clears the way for Kachlany’s company, Actinobac Biomed, to initiate a phase I clinical trial in patients...
Read more
Scientists at Sienza Energy in Pasadena, a Caltech spinoff, are developing two trendsetting batteries for electric vehicles and consumer...
Read more
Motorola has begun a plan to give its smartphones medium-distance charging technology from startup GuRu Wireless that requires not...
Read more
Most of the 5 billion people who own a mobile device would likely describe the technology that powers it...
Read more
Delpor announced that it has initiated and dosed the first patient in a phase 1b/2a clinical trial of DLP-114,...
Read more
Vivodyne's goal is to lower the bar for labs and scientists to test their own research. This Penn-founded biotech...
Read more
MixComm announced it has joined the Open RF Association (OpenRF™), an open industry consortium dedicated to creating a 5G...
Read more